These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25868067)

  • 1. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.
    Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK
    J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.
    Shaker OG; Abdel-Rahim MT; Bayoumi ST
    Cell Biochem Biophys; 2015 Mar; 71(2):617-25. PubMed ID: 25239021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.
    Suzuki F; Arase Y; Suzuki Y; Tsubota A; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Satoh J; Kumada H
    J Viral Hepat; 2004 May; 11(3):271-6. PubMed ID: 15117331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic polymorphisms of MxA protein and eIF-2a-reg2 and their responses to interferon treatment in patients with chronic hepatitis B].
    Huang YX; Ma LN; Chen XY; Li Z; Huang YL; Shen CL; Ma B
    Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):187-91. PubMed ID: 17407708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.
    El Awady MK; Anany MA; Esmat G; Zayed N; Tabll AA; Helmy A; El Zayady AR; Abdalla MS; Sharada HM; El Raziky M; El Akel W; Abdalla S; Bader El Din NG
    J Gastroenterol Hepatol; 2011 May; 26(5):843-50. PubMed ID: 21182542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.
    Naga M; Amin M; Algendy D; Elbadry A; Fawzi M; Foda A; Esmat S; Sabry D; Rashed L; Gabal S; Kamal M
    World J Gastroenterol; 2015 Oct; 21(39):11141-51. PubMed ID: 26494968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
    Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy.
    El Raziky M; Elsharkawy A; Said SE; Abdelatty S; El Akel W; Tantawy O; Gamal Eldeen H; Mabrouk M
    J Interferon Cytokine Res; 2015 Aug; 35(8):649-53. PubMed ID: 25973761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon.
    Hijikata M; Ohta Y; Mishiro S
    Intervirology; 2000; 43(2):124-7. PubMed ID: 10971132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients.
    Bader El Din NG; Anany MA; Dawood RM; Ibrahim MK; El-Shenawy R; El Abd YS; El Awady MK
    Viral Immunol; 2015 Nov; 28(9):509-16. PubMed ID: 26505957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
    Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
    J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between single nucleotide polymorphisms in -88 and -123 loci of MxA gene promoter region and HCV susceptibility and IFN-α efficacy].
    Hu CH; Chen J; Yang R; Li NN; Yang B; Ma D; Liang XC; Wang Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1307-10. PubMed ID: 23232524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of IL-10 gene in patients infected with HCV under antiviral treatment in southern Brazil.
    da Silva NM; Germano FN; Vidales-Braz BM; Carmo Zanella Rd; dos Santos DM; Lobato R; de Martinez AM
    Cytokine; 2015 Jun; 73(2):253-7. PubMed ID: 25797191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection.
    MacQuillan GC; de Boer WB; Platten MA; McCaul KA; Reed WD; Jeffrey GP; Allan JE
    J Med Virol; 2002 Oct; 68(2):197-205. PubMed ID: 12210408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.
    Kong XF; Zhang XX; Gong QM; Gao J; Zhang SY; Wang L; Xu J; Han Y; Jin GD; Jiang JH; Zhang DH; Lu ZM
    J Interferon Cytokine Res; 2007 Sep; 27(9):809-18. PubMed ID: 17892402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon.
    Nishizawa Y; Tanaka E; Orii K; Rokuhara A; Ichijo T; Yoshizawa K; Kiyosawa K
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1292-7. PubMed ID: 11129224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism in the microsomal triglyceride transfer protein can predict the response to antiviral therapy in Egyptian patients with chronic hepatitis C virus genotype 4 infection.
    Saad Y; Shaker O; Nassar Y; Ahmad L; Said M; Esmat G
    Gut Liver; 2014 Nov; 8(6):655-61. PubMed ID: 25287167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interleukin-10 gene promoter polymorphisms -1082 G/A and -592 C/A on response to therapy in children and adolescents with chronic hepatitis C virus infection.
    El-Karaksy HM; Sharaf SA; Mandour IA; Mogahed EA; Rady NH; El-Mougy FA
    Hum Immunol; 2016 Dec; 77(12):1248-1253. PubMed ID: 27660094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.